Questcor - Best Pharma Stocks on 2007

Company: Questcor
Starting stock price: $1.45
Ending stock price: $5.77
Percent Change: 298%

Details: Union City, CA-based Questcor Pharmaceuticals develops and commercializes novel CNS-focused therapeutics. With 70 workers and a market cap of $366 million, the company's stock increased an impressive 298% in 2007. It's marketed products include Doral for insomnia and H.P. Acthar Gel.

Questcor - Best Pharma Stocks on 2007
Read more on

Suggested Articles

At one point, Novartis even offered up $90 apiece for the inclisiran developer but would later say even $85 was too much, a securities filing shows.

Sanofi spent months hyping its Tuesday investor event, and new CEO Paul Hudson certainly laid out a different vision for the drugmaker at the confab.

After more than 10 years as partners, Sanofi and Regeneron are splitting up their deal to comarket PCSK9 med Praluent and immunology drug Kevzara.